Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 47.80
+1.85 (4.03%)
Jun 6, 2025, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 13.17 billion as of June 6, 2025. Its market cap has increased by 14.49% in one year.
Market Cap
13.17B
Enterprise Value
11.68B
Revenue
455.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
47.80
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 13.17B, a decrease of -28.51%. That is a compound annual growth rate of -8.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 13.17B | 54.69% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.77% |
| Dec 30, 2022 | 14.27B | 47.83% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 240.35B |
| Hansoh Pharmaceutical Group Company | 157.27B |
| JD Health International | 126.08B |
| Innovent Biologics | 119.26B |
| WuXi Biologics | 101.31B |
| CSPC Pharmaceutical Group | 89.83B |
| Sino Biopharmaceutical | 81.02B |
| Sichuan Kelun-Biotech Biopharmaceutical | 75.74B |